Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia - Takeaways - MDSpire

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • By

  • Xiandan Chen

  • Linlu Ying

  • Weixing Kong

  • Wangxiong Hu

  • Zhong Hu

  • June 2, 2026

  • 0 min

Share

  • 1

    A blood-based biomarker signature was developed to differentiate between HRSV and MP infections in pediatric patients with CAP.

  • 2

    The study utilized LASSO regression and machine learning to analyze clinical data and blood samples from infected patients.

  • 3

    The final biomarker signature included eosinophilic granulocyte, immunoglobulin A, LDH, β2-microglobulin, and albumin to globulin ratio.

  • 4

    The optimized random forest model achieved an AUC-ROC of 0.89, indicating strong diagnostic performance.

  • 5

    Further prospective, multi-center studies are needed to confirm the generalizability and clinical utility of the biomarker signature.

Original Source(s)

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • by Xiandan Chen, Linlu Ying, Weixing Kong, Wangxiong Hu, Zhong Hu

  • June 2, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Perioperative anesthetic considerations and outcomes in Crouzon syndrome: a retrospective analysis of Le Fort III advancement surgery

Uncompensated Hospitalizations in Children’s Hospitals